| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PSD TAGAP OBSCN RCC1 CHM ELMO1 PLCB1 AGFG2 DOCK6 ARHGEF6 RASA3 KALRN MADD RIC8B ARRB1 TIAM1 ARHGAP12 ITSN2 EVI5L | 3.03e-06 | 507 | 217 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PSD TAGAP OBSCN RCC1 CHM ELMO1 PLCB1 AGFG2 DOCK6 ARHGEF6 RASA3 KALRN MADD RIC8B ARRB1 TIAM1 ARHGAP12 ITSN2 EVI5L | 3.03e-06 | 507 | 217 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | PSD TAGAP OBSCN RCC1 ELMO1 DOCK6 ARHGEF6 KALRN MADD RIC8B TIAM1 ITSN2 | 8.97e-06 | 231 | 217 | 12 | GO:0005085 |
| GeneOntologyMolecularFunction | ethanol binding | 2.47e-05 | 6 | 217 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.68e-04 | 26 | 217 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.98e-04 | 30 | 217 | 4 | GO:0018455 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 2.37e-05 | 17 | 213 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 3.02e-05 | 18 | 213 | 4 | GO:0006067 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYL4 SPAST ILK MDM1 OBSCN EVPL CMYA5 NEB EFHB KRT80 GABARAPL1 AHNAK SYNE2 GABARAPL3 LMNTD1 SDC4 CNP CUL3 CACNA1S DNAH3 CEP162 GAS7 ABCC9 PPL DNAH1 LMOD3 DNAH12 TIAM1 HAUS1 TPX2 DYNC1LI1 MAP2K2 DMTN AHNAK2 | 6.06e-08 | 1179 | 217 | 34 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYL4 SPAST ILK MDM1 OBSCN EVPL CMYA5 NEB EFHB KRT80 GABARAPL1 AHNAK SYNE2 GABARAPL3 LMNTD1 SDC4 CNP CUL3 CACNA1S DNAH3 CEP162 GAS7 ABCC9 PPL DNAH1 LMOD3 DNAH12 TIAM1 HAUS1 TPX2 DYNC1LI1 MAP2K2 DMTN AHNAK2 | 7.12e-08 | 1187 | 217 | 34 | GO:0099081 |
| GeneOntologyCellularComponent | costamere | 2.63e-06 | 22 | 217 | 5 | GO:0043034 | |
| GeneOntologyCellularComponent | myofibril | MYL4 ILK OBSCN CMYA5 NEB AHNAK SYNE2 SDC4 CACNA1S ABCC9 LMOD3 AHNAK2 | 3.02e-05 | 273 | 217 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYL4 ILK OBSCN CMYA5 NEB AHNAK SYNE2 SDC4 CACNA1S ABCC9 LMOD3 AHNAK2 | 5.42e-05 | 290 | 217 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | inner dynein arm | 1.25e-04 | 10 | 217 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule | SPAST MDM1 EFHB GABARAPL1 GABARAPL3 CNP CUL3 DNAH3 CEP162 DNAH1 DNAH12 TIAM1 HAUS1 TPX2 DYNC1LI1 MAP2K2 | 1.51e-04 | 533 | 217 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | SPAST MDM1 EVPL EFHB KRT80 GABARAPL1 GABARAPL3 LMNTD1 CNP CUL3 DNAH3 CEP162 GAS7 PPL DNAH1 DNAH12 TIAM1 HAUS1 TPX2 DYNC1LI1 MAP2K2 DMTN | 1.78e-04 | 899 | 217 | 22 | GO:0099513 |
| GeneOntologyCellularComponent | sarcomere | 2.88e-04 | 249 | 217 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | SPAST EFHB GABARAPL1 ATG16L1 DNAH3 CEP162 ARMCX3 MADD DNAH1 DNAH12 HYDIN | 5.02e-04 | 317 | 217 | 11 | GO:0032838 |
| MousePheno | abnormal Z line morphology | 8.34e-06 | 40 | 171 | 6 | MP:0004091 | |
| MousePheno | abnormal I band morphology | 1.12e-05 | 42 | 171 | 6 | MP:0030567 | |
| MousePheno | abnormal ethanol metabolism | 3.50e-05 | 6 | 171 | 3 | MP:0005443 | |
| MousePheno | abnormal sarcomere morphology | 4.24e-05 | 77 | 171 | 7 | MP:0004090 | |
| MousePheno | abnormal retinol metabolism | 6.07e-05 | 7 | 171 | 3 | MP:0005444 | |
| Domain | PH_dom-like | PSD OBSCN ELMO1 RTKN2 PLCL2 PLCB1 PLCB4 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP FRMD4A TIAM1 ARHGAP12 ITSN2 PLEKHA1 FRMPD3 | 5.71e-07 | 426 | 216 | 19 | IPR011993 |
| Domain | PH | PSD OBSCN ELMO1 RTKN2 PLCL2 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP TIAM1 ARHGAP12 ITSN2 PLEKHA1 | 8.93e-07 | 278 | 216 | 15 | SM00233 |
| Domain | PH_DOMAIN | PSD OBSCN ELMO1 RTKN2 PLCL2 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP TIAM1 ARHGAP12 ITSN2 PLEKHA1 | 9.34e-07 | 279 | 216 | 15 | PS50003 |
| Domain | PH_domain | PSD OBSCN ELMO1 RTKN2 PLCL2 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP TIAM1 ARHGAP12 ITSN2 PLEKHA1 | 9.77e-07 | 280 | 216 | 15 | IPR001849 |
| Domain | ADH_Zn_CS | 1.17e-06 | 8 | 216 | 4 | IPR002328 | |
| Domain | ADH_ZINC | 1.17e-06 | 8 | 216 | 4 | PS00059 | |
| Domain | PH | PSD OBSCN RTKN2 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP TIAM1 ARHGAP12 ITSN2 PLEKHA1 | 2.78e-06 | 229 | 216 | 13 | PF00169 |
| Domain | - | PSD OBSCN ELMO1 RTKN2 PLCL2 PLCB4 PLD1 PLEKHA7 ARHGEF6 RASA3 KALRN TRIOBP FRMD4A TIAM1 ARHGAP12 ITSN2 PLEKHA1 | 3.24e-06 | 391 | 216 | 17 | 2.30.29.30 |
| Domain | ADH_N | 2.84e-05 | 16 | 216 | 4 | PF08240 | |
| Domain | ADH_N | 2.84e-05 | 16 | 216 | 4 | IPR013154 | |
| Domain | SH3_9 | 3.31e-05 | 78 | 216 | 7 | PF14604 | |
| Domain | - | 4.69e-05 | 18 | 216 | 4 | 3.90.180.10 | |
| Domain | - | DDX59 SPAST RAB10 GUF1 NWD2 RHOBTB2 DDX54 HS3ST1 CNP VCP DNAH3 NTPCR ABCC9 DNAH1 ARL4C EEF2 DNAH12 DDX25 HELZ2 DYNC1LI1 SNRNP200 HYDIN | 5.66e-05 | 746 | 216 | 22 | 3.40.50.300 |
| Domain | ADH_zinc_N | 5.88e-05 | 19 | 216 | 4 | PF00107 | |
| Domain | ADH_SF_Zn-type | 5.88e-05 | 19 | 216 | 4 | IPR002085 | |
| Domain | ADH_C | 5.88e-05 | 19 | 216 | 4 | IPR013149 | |
| Domain | GroES-like | 1.54e-04 | 24 | 216 | 4 | IPR011032 | |
| Domain | SH3 | OBSCN NEB TXK MAP3K10 ARHGEF6 KALRN SH3KBP1 GAS7 ARHGAP12 ITSN2 | 2.17e-04 | 216 | 216 | 10 | SM00326 |
| Domain | SH3 | OBSCN NEB TXK MAP3K10 ARHGEF6 KALRN SH3KBP1 GAS7 ARHGAP12 ITSN2 | 2.17e-04 | 216 | 216 | 10 | PS50002 |
| Domain | SH3_domain | OBSCN NEB TXK MAP3K10 ARHGEF6 KALRN SH3KBP1 GAS7 ARHGAP12 ITSN2 | 2.51e-04 | 220 | 216 | 10 | IPR001452 |
| Domain | AAA | 2.75e-04 | 144 | 216 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.75e-04 | 144 | 216 | 8 | IPR003593 | |
| Domain | Spectrin_repeat | 3.29e-04 | 29 | 216 | 4 | IPR002017 | |
| Domain | - | 3.31e-04 | 148 | 216 | 8 | 2.60.40.150 | |
| Domain | P-loop_NTPase | DDX59 SPAST RAB10 GUF1 NWD2 RHOBTB2 DDX54 HS3ST1 CNP VCP DNAH3 NTPCR ABCC9 DNAH1 ARL4C EEF2 DNAH12 DDX25 HELZ2 DYNC1LI1 SNRNP200 HYDIN | 3.49e-04 | 848 | 216 | 22 | IPR027417 |
| Domain | PLC-beta_CS | 3.96e-04 | 3 | 216 | 2 | IPR009535 | |
| Domain | DUF1154 | 3.96e-04 | 3 | 216 | 2 | PF06631 | |
| Domain | SPEC | 4.85e-04 | 32 | 216 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.85e-04 | 32 | 216 | 4 | IPR018159 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.05e-04 | 14 | 216 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.05e-04 | 14 | 216 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.05e-04 | 14 | 216 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.05e-04 | 14 | 216 | 3 | IPR011704 | |
| Domain | AAA_8 | 5.05e-04 | 14 | 216 | 3 | PF12780 | |
| Domain | AAA_5 | 5.05e-04 | 14 | 216 | 3 | PF07728 | |
| Domain | DHC_fam | 6.26e-04 | 15 | 216 | 3 | IPR026983 | |
| Domain | EF-hand_like | 6.26e-04 | 15 | 216 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 6.26e-04 | 15 | 216 | 3 | PF00387 | |
| Domain | PLCYc | 6.26e-04 | 15 | 216 | 3 | SM00149 | |
| Domain | Dynein_heavy | 6.26e-04 | 15 | 216 | 3 | PF03028 | |
| Domain | PLipase_C_Pinositol-sp_Y | 6.26e-04 | 15 | 216 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 6.26e-04 | 15 | 216 | 3 | PS50008 | |
| Domain | Dynein_heavy_dom | 6.26e-04 | 15 | 216 | 3 | IPR004273 | |
| Domain | PI-PLC_fam | 6.26e-04 | 15 | 216 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 6.26e-04 | 15 | 216 | 3 | IPR015359 | |
| Domain | C2_dom | 6.56e-04 | 164 | 216 | 8 | IPR000008 | |
| Domain | SH3_1 | 6.56e-04 | 164 | 216 | 8 | PF00018 | |
| Domain | PLC-beta | 7.87e-04 | 4 | 216 | 2 | IPR016280 | |
| Domain | C2 | 8.35e-04 | 131 | 216 | 7 | PF00168 | |
| Domain | C2 | 1.09e-03 | 137 | 216 | 7 | SM00239 | |
| Domain | PI-PLC-X | 1.09e-03 | 18 | 216 | 3 | PF00388 | |
| Domain | PLCXc | 1.09e-03 | 18 | 216 | 3 | SM00148 | |
| Domain | RhoGEF | 1.14e-03 | 68 | 216 | 5 | SM00325 | |
| Domain | PDZ | 1.28e-03 | 141 | 216 | 7 | PF00595 | |
| Domain | PIPLC_X_DOMAIN | 1.29e-03 | 19 | 216 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.29e-03 | 19 | 216 | 3 | IPR000909 | |
| Domain | RhoGEF | 1.30e-03 | 70 | 216 | 5 | PF00621 | |
| Domain | DH_2 | 1.30e-03 | 70 | 216 | 5 | PS50010 | |
| Domain | C2 | 1.34e-03 | 142 | 216 | 7 | PS50004 | |
| Domain | - | 1.38e-03 | 71 | 216 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.38e-03 | 71 | 216 | 5 | IPR000219 | |
| Domain | PDZ | 1.70e-03 | 148 | 216 | 7 | SM00228 | |
| Domain | - | 1.83e-03 | 150 | 216 | 7 | 2.30.42.10 | |
| Domain | PDZ | 1.90e-03 | 151 | 216 | 7 | PS50106 | |
| Domain | EFG_C | 1.94e-03 | 6 | 216 | 2 | PF00679 | |
| Domain | EFG_III-V | 1.94e-03 | 6 | 216 | 2 | IPR009022 | |
| Domain | EFG_C | 1.94e-03 | 6 | 216 | 2 | SM00838 | |
| Domain | PH_12 | 1.94e-03 | 6 | 216 | 2 | PF16457 | |
| Domain | PDZ | 1.97e-03 | 152 | 216 | 7 | IPR001478 | |
| Domain | Plectin | 2.69e-03 | 7 | 216 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.69e-03 | 7 | 216 | 2 | IPR001101 | |
| Domain | - | 2.69e-03 | 7 | 216 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 2.69e-03 | 7 | 216 | 2 | IPR000640 | |
| Domain | PLEC | 2.69e-03 | 7 | 216 | 2 | SM00250 | |
| Domain | - | 2.91e-03 | 25 | 216 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 2.91e-03 | 25 | 216 | 3 | IPR017946 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 5.21e-06 | 11 | 162 | 4 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 7.74e-06 | 12 | 162 | 4 | M14663 | |
| Pathway | PID_RAC1_REG_PATHWAY | 6.96e-05 | 38 | 162 | 5 | M241 | |
| Pubmed | WDR33 PSMD1 RCC1 LRRC59 NEB TASOR2 ACSL3 RAB10 BRCA1 PRRC2C AHNAK SYNE2 SYNCRIP PCDHGC4 ZSWIM5 RBBP8 PPP1R9A HEATR1 SRBD1 UBLCP1 PRX PPL SEC61A2 LMOD3 SEPHS1 EEF2 ARRB1 KIAA0825 ARHGAP12 ITSN2 PLXNA4 ZFR CUX1 GABPA | 4.52e-11 | 1442 | 221 | 34 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPAST ILK CDK14 MAST2 FSIP2 PIK3C2B PRRC2C AHNAK SYNE2 MAP3K10 DOCK6 PLEKHA7 CFAP97 CAMKK1 MAP7D3 CEP162 NSMCE2 MADD KIAA1671 TIAM1 TET1 MEPCE PLEKHA1 MAP2K2 DMTN AHNAK2 | 5.99e-11 | 861 | 221 | 26 | 36931259 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | LYRM7 ESS2 EARS2 WDR33 VPS13C PSMD1 LRRC59 ACSL3 RAB10 GUF1 WIZ SYNE2 DDX54 CLN6 UTP3 CNP VCP SYNCRIP MAP7D3 NTPCR MRPL13 MRPL28 HEATR1 ARMCX3 KIAA1671 SEC61A2 SPATS2L ARHGAP12 ITSN2 ZFR MRPL40 CUX1 AHNAK2 | 4.94e-10 | 1496 | 221 | 33 | 32877691 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EVPL LRRC59 KRT80 TASOR2 PRRC2C AHNAK DDX54 MKI67 PRMT1 POLR1B UTP3 SDC4 CNP SYNCRIP CUL3 MAP7D3 MRPL28 HEATR1 SRBD1 PPL KIAA1671 ACTR1A EEF2 SPATS2L TPX2 HELZ2 MEPCE ZFR SNRNP200 DMTN | 5.33e-10 | 1257 | 221 | 30 | 36526897 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CTTNBP2NL TASOR2 RTKN2 PIGR AHNAK MKI67 PRMT1 CFAP97 VCP ANAPC4 SYNCRIP NAA16 CUL3 SH3KBP1 TRIOBP CCDC12 NSMCE2 PPL ACTR1A PPP2R5C ARRB1 HAUS1 ITSN2 TPX2 DYNC1LI1 ZFR SNRNP200 ZMYM3 | 1.51e-09 | 1155 | 221 | 28 | 20360068 |
| Pubmed | PSMD1 RCC1 ADH5 ACSL3 RAB10 WIZ AHNAK SYNE2 PLCL2 DDX54 MKI67 UTP3 PLEKHA7 RELCH CEP162 PPP1R9A TRIOBP UBLCP1 MADD KIAA1671 PPP2R5C TIAM1 HAUS1 OTUD4 CSTF3 PLEKHA1 | 3.87e-09 | 1049 | 221 | 26 | 27880917 | |
| Pubmed | ESS2 TAGAP WDR33 LRRC59 ELMO1 AHNAK CLN6 DOCK6 PLEKHA7 ARHGEF6 ANKFY1 SH3KBP1 MRPL28 HEATR1 CCDC12 KIAA1671 PPP2R5C TIAM1 ARHGAP12 ITSN2 TPX2 DYNC1LI1 ZFR EVI5L | 5.56e-09 | 916 | 221 | 24 | 32203420 | |
| Pubmed | 7.89e-09 | 5 | 221 | 4 | 8621625 | ||
| Pubmed | 7.89e-09 | 5 | 221 | 4 | 7738026 | ||
| Pubmed | 7.89e-09 | 5 | 221 | 4 | 8892527 | ||
| Pubmed | 7.89e-09 | 5 | 221 | 4 | 10358022 | ||
| Pubmed | SPAST ILK ESS2 RCC1 ELMO1 RAB10 WIZ BRCA1 PRRC2C MKI67 PRMT1 SYNCRIP CUL3 NTPCR ZNF507 CCDC12 ACTR1A EEF2 TPX2 CSTF3 DYNC1LI1 ZFR SNRNP200 ZMYM3 CUX1 GABPA | 1.07e-08 | 1103 | 221 | 26 | 34189442 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 ILK PSMD1 RCC1 ACSL3 GUF1 AHNAK DDX54 MKI67 PRMT1 POLR1B SDC4 CNP VCP SYNCRIP ANKFY1 GNE RASA3 HEATR1 SRBD1 ACTR1A EEF2 MAP4K5 DYNC1LI1 ZFR PRMT3 SNRNP200 ZMYM3 AHNAK2 | 1.17e-08 | 1353 | 221 | 29 | 29467282 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | WDR33 PRRC2C DDX54 PRMT1 UTP3 METTL16 VCP SYNCRIP MTHFSD NTPCR MRPL13 HEATR1 PCDH20 EEF2 SPATS2L HELZ2 MEPCE OTUD4 CSTF3 ZFR MRPL40 SNRNP200 | 1.24e-08 | 807 | 221 | 22 | 22681889 |
| Pubmed | PSMD1 EVPL NEB RTKN2 POM121 NFYC PLCB1 MAP3K10 GAS7 LCP2 MADD ARRB1 MAP4K5 ITSN2 MAP2K2 SNRNP200 CUX1 | 1.76e-08 | 486 | 221 | 17 | 20936779 | |
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 2.36e-08 | 6 | 221 | 4 | 17185388 | |
| Pubmed | 2.36e-08 | 6 | 221 | 4 | 12027900 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | LYRM7 VPS13C TSPYL2 OBSCN PSMD1 CDK14 RXRA TASOR2 RAB10 PLCB4 DOCK6 CRAMP1 RASA3 PPP1R9A TRIOBP CCDC12 NSMCE2 GTF2IRD1 UBLCP1 DNAH1 KIAA1671 RIC8B ARRB1 USP40 DIP2C CSTF3 STK38L MAP2K2 CUX1 EVI5L | 2.54e-08 | 1489 | 221 | 30 | 28611215 |
| Pubmed | TSPYL2 EVPL LRRC59 WIZ DDX54 MKI67 POLR1B PLD1 UTP3 VCP MRPL28 HEATR1 CCDC12 ACTR1A SPATS2L TPX2 MEPCE CSTF3 ZFR SNRNP200 ZMYM3 CUX1 | 2.91e-08 | 847 | 221 | 22 | 35850772 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 PSMD1 RCC1 CTTNBP2NL ACSL3 MKI67 ARHGEF6 CUL3 RBBP8 ZNF507 GTF2IRD1 PPL EEF2 TPX2 CTDP1 HELZ2 OTUD4 DYNC1LI1 MAP2K2 SNRNP200 ZMYM3 | 2.93e-08 | 774 | 221 | 21 | 15302935 |
| Pubmed | ESS2 WDR33 PSMD1 TNIP1 LRRC59 RXRA WIZ BRCA1 PRRC2C SYNE2 DDX54 MKI67 NFYC PRMT1 SYNCRIP SH3KBP1 ZNF507 MRPL13 MRPL28 KIAA1671 TPX2 OTUD4 ZFR HAGH PAX7 CABIN1 ZMYM3 CUX1 GABPA | 3.81e-08 | 1429 | 221 | 29 | 35140242 | |
| Pubmed | OBSCN POM121 WIZ BRCA1 DDX54 MKI67 LMNTD1 RBBP8 GTF2IRD1 TPX2 | 4.43e-08 | 149 | 221 | 10 | 25184681 | |
| Pubmed | 5.47e-08 | 7 | 221 | 4 | 16047160 | ||
| Pubmed | 5.47e-08 | 7 | 221 | 4 | 11784316 | ||
| Pubmed | 5.47e-08 | 7 | 221 | 4 | 16685648 | ||
| Pubmed | 5.47e-08 | 7 | 221 | 4 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 5.47e-08 | 7 | 221 | 4 | 23468174 | |
| Pubmed | UBA5 SPAST EVPL PRRC2C AHNAK PPP1R9A TRIOBP PPL MAP4K5 MMRN2 DYNC1LI1 ZFR GABPA AHNAK2 | 9.14e-08 | 360 | 221 | 14 | 33111431 | |
| Pubmed | 1.09e-07 | 8 | 221 | 4 | 18331377 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | ILK PSMD1 KRT80 ACSL3 PIK3C2B PRRC2C AHNAK PRMT1 VCP SYNCRIP ANKFY1 MRPL13 ACTR1A EEF2 SPATS2L OTUD4 STK38L | 1.28e-07 | 558 | 221 | 17 | 27591049 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SPAST VPS13C EVPL NEB ADH5 RAB10 WIZ PIGR AHNAK PLEKHA7 CNP VCP NAA16 CUL3 ANKFY1 KALRN PPL ACTR1A EEF2 ITSN2 MMRN2 PLEKHA1 CCDC180 | 1.64e-07 | 1016 | 221 | 23 | 19056867 |
| Pubmed | 1.95e-07 | 9 | 221 | 4 | 31541646 | ||
| Pubmed | 2.53e-07 | 3 | 221 | 3 | 21940993 | ||
| Pubmed | RAB10 WIZ PRRC2C SYNE2 PLCB1 PRMT1 GOLGA1 CNP CUL3 ANKFY1 KALRN PPP1R9A SH3KBP1 TRIOBP ACTR1A EEF2 BCL11B OTUD4 ZFR FRMPD3 CABIN1 CUX1 | 2.66e-07 | 963 | 221 | 22 | 28671696 | |
| Pubmed | SPAST EARS2 VPS13C CDK14 CTTNBP2NL PLCB1 DOCK6 CRAMP1 CFAP97 CUL3 RELCH CEP162 ZNF507 TRIOBP PPP2R5C TET1 | 3.33e-07 | 529 | 221 | 16 | 14621295 | |
| Pubmed | CTTNBP2NL RAB10 GUF1 WIZ BRCA1 PRMT1 POLR1B UTP3 PLEKHA7 SDC4 CNP PPP1R9A NTPCR TRIOBP HEATR1 SRBD1 KIAA1671 ACTR1A PPP2R5C ARRB1 SPATS2L ITSN2 TPX2 HELZ2 OTUD4 CSTF3 ZMYM3 GABPA | 3.51e-07 | 1497 | 221 | 28 | 31527615 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MYL4 NWD2 GABARAPL1 PRRC2C PLCB1 VCP SYNCRIP KALRN MADD EEF2 SPATS2L ARHGAP12 OTUD4 DYNC1LI1 ZFR | 4.57e-07 | 475 | 221 | 15 | 31040226 |
| Pubmed | WDR33 PSMD1 TNIP1 BRCA1 PIK3C2B AHNAK RNF216 PRMT1 SDC4 VCP CUL3 GTF2IRD1 ITSN2 USP40 OTUD4 | 5.35e-07 | 481 | 221 | 15 | 28190767 | |
| Pubmed | ESS2 KRT80 ACSL3 PRRC2C AHNAK MKI67 SYNCRIP GNE EEF2 TPX2 HELZ2 AHNAK2 | 5.35e-07 | 298 | 221 | 12 | 30737378 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 5.90e-07 | 111 | 221 | 8 | 22558309 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 7.13e-07 | 27 | 221 | 5 | 24741061 | |
| Pubmed | 7.55e-07 | 12 | 221 | 4 | 12128098 | ||
| Pubmed | PLVAP NEB RAB10 SYNE2 PLCB1 ANKFY1 MAP7D3 NTPCR MRPL28 LRR1 DNAH12 ASXL3 ITSN2 OTUD4 MAP2K2 CUX1 AHNAK2 | 8.22e-07 | 638 | 221 | 17 | 31182584 | |
| Pubmed | UBA5 PSMD1 LRRC59 DNAJB5 CNP VCP SYNCRIP ANKFY1 NTPCR HEATR1 ACTR1A EEF2 CSTF3 DYNC1LI1 PRMT3 MAP2K2 SNRNP200 | 8.22e-07 | 638 | 221 | 17 | 33239621 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WDR33 RCC1 LRRC59 TASOR2 WIZ BRCA1 PRRC2C AHNAK MKI67 UTP3 ANAPC4 SYNCRIP MAP7D3 NTPCR HEATR1 EEF2 TPX2 CSTF3 ZFR SNRNP200 CUX1 | 9.13e-07 | 954 | 221 | 21 | 36373674 |
| Pubmed | 9.40e-07 | 118 | 221 | 8 | 30979931 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 9733106 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 9202249 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 1.01e-06 | 4 | 221 | 3 | 3996732 | |
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 9241435 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 38019906 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 2893758 | ||
| Pubmed | 1.01e-06 | 4 | 221 | 3 | 9002638 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | TSPYL2 BRCA1 RNF216 VCP ANKFY1 NTPCR HEATR1 ARMCX3 EEF2 SPATS2L ZMYM3 | 1.07e-06 | 262 | 221 | 11 | 36880596 |
| Pubmed | Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. | 1.08e-06 | 13 | 221 | 4 | 28402856 | |
| Pubmed | PSMD1 EVPL RCC1 LRRC59 RAB10 BRCA1 PIGR AHNAK MKI67 VCP SYNCRIP RBBP8 HEATR1 PPL EEF2 TPX2 SNRNP200 | 1.10e-06 | 652 | 221 | 17 | 31180492 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PSMD1 RCC1 LRRC59 ADH5 RAB10 RTKN2 GUF1 AHNAK PRMT1 VCP SYNCRIP EPG5 DNAH1 ACTR1A EEF2 MYOCD SNRNP200 HYDIN AHNAK2 | 1.16e-06 | 807 | 221 | 19 | 30575818 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | EVPL MAST2 ADH7 ACSL3 RAB10 UTP3 TRIOBP MRPL28 HEATR1 PPL KIAA1671 ACTR1A FRMD4A EEF2 SPATS2L HELZ2 ZFR CUX1 | 1.22e-06 | 732 | 221 | 18 | 34732716 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TMEM237 ACSL3 RAB10 POM121 AHNAK PLCL2 PRMT1 PLEKHA7 CNP ARHGEF6 SYNCRIP CUL3 ATG16L1 RELCH MAP7D3 NTPCR HEATR1 KIAA1671 ACTR1A PPP2R5C TIAM1 HAUS1 DYNC1LI1 CFAP418 SNRNP200 | 1.27e-06 | 1321 | 221 | 25 | 27173435 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | VPS13C LRRC59 PRRC2C AHNAK DDX54 VCP ATG16L1 EEF2 SPATS2L SNRNP200 AHNAK2 | 1.33e-06 | 268 | 221 | 11 | 33024031 |
| Pubmed | UBR1 POLR3D PRMT1 METTL16 SYNCRIP NTPCR ARMCX3 FRMD4A CTDP1 MEPCE ZFR MAP2K2 SNRNP200 | 1.50e-06 | 390 | 221 | 13 | 17643375 | |
| Pubmed | 1.51e-06 | 14 | 221 | 4 | 33203851 | ||
| Pubmed | 1.73e-06 | 32 | 221 | 5 | 17270348 | ||
| Pubmed | ILK ATP7B TMEM237 PSMD1 LRRC59 ELMO1 ACSL3 PRRC2C AHNAK DDX54 MKI67 AGFG2 CLN6 PLD1 CNP SYNCRIP CUL3 MAP7D3 NTPCR HEATR1 EEF2 HELZ2 DYNC1LI1 | 1.80e-06 | 1168 | 221 | 23 | 19946888 | |
| Pubmed | PSMD1 RCC1 LRRC59 ACSL3 PRRC2C AHNAK SYNE2 DDX54 MKI67 PRMT1 CNP VCP SYNCRIP TRIOBP MRPL28 HEATR1 KIAA1671 ACTR1A EEF2 DYNC1LI1 ZFR CABIN1 SNRNP200 CUX1 EVI5L AHNAK2 | 1.83e-06 | 1440 | 221 | 26 | 30833792 | |
| Pubmed | TNIP1 RHOBTB2 SYNE2 PLCB1 ANKFY1 TRIOBP HELZ2 DIP2C STK38L SNRNP200 | 2.00e-06 | 225 | 221 | 10 | 12168954 | |
| Pubmed | 2.05e-06 | 15 | 221 | 4 | 29045729 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBA5 ILK PSMD1 CMYA5 CTTNBP2NL SPDL1 AHNAK PRMT1 VCP SYNCRIP CUL3 CACNA1S ATG16L1 RELCH ANKFY1 GNE ARMCX3 ACTR1A EEF2 PPP2R5C MEPCE DYNC1LI1 PRMT3 SNRNP200 GABPA AHNAK2 | 2.20e-06 | 1455 | 221 | 26 | 22863883 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBA5 UBR1 ILK LRRC59 CTTNBP2NL KRT80 ACSL3 RAB10 AHNAK SYNE2 CLN6 SDC4 CNP VCP UBLCP1 PPL ACTR1A SEPHS1 EEF2 SPATS2L CSTF3 ZFR HAGH CFAP418 AHNAK2 | 2.34e-06 | 1367 | 221 | 25 | 32687490 |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 11836246 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 2.51e-06 | 5 | 221 | 3 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 2.51e-06 | 5 | 221 | 3 | 22079585 | |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 7026729 | ||
| Pubmed | UBA5 SPAST RAB10 PIK3C2B VCP RELCH MAP7D3 HEATR1 HAUS1 DYNC1LI1 ZFR | 2.67e-06 | 288 | 221 | 11 | 23383273 | |
| Pubmed | WDR33 TNIP1 RCC1 SPDL1 WIZ PRRC2C AHNAK MAP7D3 HEATR1 KIAA1671 TET1 TPX2 ZFR SNRNP200 CUX1 | 2.74e-06 | 549 | 221 | 15 | 38280479 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | WDR33 MDM1 RCC1 ADH5 SYNE2 MKI67 HEATR1 BCL11B TPX2 ZFR ZMYM3 | 2.76e-06 | 289 | 221 | 11 | 23752268 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PSMD1 RCC1 LRRC59 KRT80 ACSL3 RAB10 POM121 AHNAK SYNE2 DDX54 MKI67 PRMT1 CNP VCP SYNCRIP PPP1R9A HEATR1 KIAA1671 CSTF3 ZFR SNRNP200 | 2.78e-06 | 1024 | 221 | 21 | 24711643 |
| Pubmed | VPS13C KIAA0319L TASOR2 WIZ BRCA1 AHNAK MKI67 PLD1 MAP7D3 CEP162 ARMCX3 PPL KIAA1671 ARL4C EEF2 ZFR SNRNP200 CUX1 | 2.81e-06 | 777 | 221 | 18 | 35844135 | |
| Pubmed | TASOR2 WIZ PRRC2C PRMT1 CNP VCP SYNCRIP ANKFY1 SRBD1 EEF2 OTUD4 ZFR PRMT3 STK38L SNRNP200 | 2.86e-06 | 551 | 221 | 15 | 34728620 | |
| Pubmed | PSMD1 TNIP1 RCC1 SPDL1 WIZ AHNAK ANKFY1 RBBP8 ZNF507 KIAA1671 TET1 ZMYM3 CUX1 | 3.20e-06 | 418 | 221 | 13 | 34709266 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TNIP1 LRRC59 RAB10 GABARAPL1 AHNAK DDX54 MKI67 POLR1B UTP3 VCP SYNCRIP MAP7D3 PPP1R9A HEATR1 ACTR1A EEF2 TPX2 MEPCE ZFR SNRNP200 | 3.23e-06 | 949 | 221 | 20 | 36574265 |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | ESS2 EARS2 POLR3D WIZ UTP3 METTL16 GNE NSMCE2 SEPHS1 HAUS1 SLC34A1 MEPCE HAGH | 3.28e-06 | 419 | 221 | 13 | 33001583 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | UBA5 ESS2 TNIP1 AXIN1 POLR3D GABARAPL1 PIK3C2B AGFG2 RNF216 DOCK6 ANAPC4 ATG16L1 FBXW10 MADD RIC8B HAUS1 ARHGAP12 OTUD4 PRMT3 MAP2K2 EVI5L | 3.43e-06 | 1038 | 221 | 21 | 26673895 |
| Pubmed | Neural development is dependent on the function of specificity protein 2 in cell cycle progression. | 3.54e-06 | 17 | 221 | 4 | 23293287 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | OBSCN NEB PIK3C2B DDX54 PLCB4 UTP3 GOLGA1 ANAPC4 LCP2 DNAH12 KIAA0825 MEPCE ZFR HYDIN | 4.18e-06 | 497 | 221 | 14 | 36774506 |
| Pubmed | ILK OBSCN PSMD1 TNIP1 CMYA5 NEB MAST2 SYNE2 DNAJB5 VCP ANKFY1 KALRN GAS7 PAX7 | 4.18e-06 | 497 | 221 | 14 | 23414517 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 4.19e-06 | 38 | 221 | 5 | 38086370 | |
| Pubmed | DDX59 ESS2 WDR33 RAB10 BRCA1 AHNAK CNP ARHGEF6 CUL3 MAP7D3 CEP162 SRBD1 ACTR1A HAUS1 TPX2 CABIN1 | 4.34e-06 | 645 | 221 | 16 | 25281560 | |
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 4.99e-06 | 6 | 221 | 3 | 16121213 | |
| Pubmed | 4.99e-06 | 6 | 221 | 3 | 17257171 | ||
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 4.99e-06 | 6 | 221 | 3 | 9982 | |
| Pubmed | 4.99e-06 | 6 | 221 | 3 | 518534 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ESS2 RCC1 RAB10 AHNAK DDX54 MKI67 NFYC PRMT1 UTP3 VCP SYNCRIP HEATR1 SRBD1 NSMCE2 EEF2 SPATS2L TPX2 MEPCE ZFR SNRNP200 | 5.95e-06 | 989 | 221 | 20 | 36424410 |
| Pubmed | 6.16e-06 | 41 | 221 | 5 | 25452572 | ||
| Pubmed | MAST2 CTTNBP2NL ACSL3 DOCK6 PLEKHA7 CAMKK1 CEP162 PPP1R9A KIAA1671 PLEKHA1 STK38L MAP2K2 DMTN | 6.44e-06 | 446 | 221 | 13 | 24255178 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | WDR33 RCC1 LRRC59 RAB10 NWD2 WIZ PRMT1 DOCK6 ARHGEF6 VCP SYNCRIP KALRN TRIOBP GTF2IRD1 EEF2 HELZ2 CSTF3 DYNC1LI1 MRPL40 SNRNP200 ZMYM3 | 6.46e-06 | 1082 | 221 | 21 | 38697112 |
| Pubmed | 7.10e-06 | 20 | 221 | 4 | 25535916 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ILK WDR33 PSMD1 LRRC59 CMYA5 CDK14 MAST2 AXIN1 RAB10 PIGR PRMT1 VCP SYNCRIP ATG16L1 CEP162 PARP3 HEATR1 ARRB1 TIAM1 OTUD4 CSTF3 STK38L SNRNP200 | 8.50e-06 | 1284 | 221 | 23 | 17353931 |
| Pubmed | PIK3C2B RNF216 SDC4 CNP VCP CUL3 RELCH ANKFY1 MAP7D3 GTF2IRD1 MADD LRR1 ITSN2 OTUD4 MRPL40 | 8.58e-06 | 604 | 221 | 15 | 38803224 | |
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 26043730 | ||
| Interaction | YWHAH interactions | SPAST CDK14 MAST2 PIK3C2B PRRC2C AHNAK SYNE2 MAP3K10 PRMT1 DOCK6 PLEKHA7 ARHGEF6 CFAP97 VCP CUL3 ATG16L1 CAMKK1 MAP7D3 CEP162 NSMCE2 MADD KIAA1671 FRMD4A ARRB1 TIAM1 TET1 MEPCE PLEKHA1 MAP2K2 DMTN AHNAK2 | 1.03e-06 | 1102 | 218 | 31 | int:YWHAH |
| Interaction | HNRNPA1 interactions | UBR1 WDR33 TSPYL2 PSMD1 TNIP1 NEB KRT80 SPDL1 RNF150 BRCA1 MKI67 PRMT1 VCP SYNCRIP CUL3 ATG16L1 MRPL13 MRPL28 PPL FRMD4A EEF2 ARRB1 ASXL3 MEPCE CSTF3 ZFR PRMT3 SNRNP200 | 1.33e-06 | 945 | 218 | 28 | int:HNRNPA1 |
| Interaction | HDAC2 interactions | ESS2 CHM KRT80 ACSL3 WIZ BRCA1 PRRC2C AHNAK MKI67 PRMT1 VCP SYNCRIP CUL3 ATG16L1 GNE RBBP8 ACTR1A EEF2 BCL11B TET1 TPX2 HELZ2 MEPCE CABIN1 ZMYM3 AHNAK2 | 2.53e-06 | 865 | 218 | 26 | int:HDAC2 |
| Interaction | IPO5 interactions | TNIP1 SPDL1 POM121 GABARAPL1 BRCA1 MKI67 VCP CUL3 ATG16L1 CEP162 ARMCX3 HAUS1 MEPCE DYNC1LI1 PRMT3 MAP2K2 ZMYM3 | 2.89e-06 | 414 | 218 | 17 | int:IPO5 |
| Interaction | YWHAG interactions | SPAST PSMD1 CDK14 MAST2 PIK3C2B PRRC2C SYNE2 MAP3K10 PRMT1 PLEKHA7 ARHGEF6 CFAP97 VCP CUL3 ATG16L1 CAMKK1 MAP7D3 CEP162 KIAA1671 FRMD4A ARRB1 TIAM1 MAP4K5 TET1 MEPCE PLEKHA1 MAP2K2 SNRNP200 PRLR ZMYM3 DMTN AHNAK2 | 4.80e-06 | 1248 | 218 | 32 | int:YWHAG |
| Interaction | CIT interactions | ILK RCC1 LRRC59 CMYA5 ACSL3 RAB10 BRCA1 PRRC2C AHNAK SYNE2 MKI67 POLR1B UTP3 ARHGEF6 SYNCRIP CUL3 KALRN MRPL28 HEATR1 SRBD1 SYT10 KIAA1671 SEC61A2 EEF2 DNAH12 TPX2 CTDP1 MEPCE CSTF3 ZFR HAGH CCDC180 SNRNP200 CUX1 AHNAK2 | 6.20e-06 | 1450 | 218 | 35 | int:CIT |
| Interaction | PPIA interactions | WDR33 TNIP1 LRRC59 CTTNBP2NL SPDL1 RAB10 AHNAK RHOBTB2 MKI67 PRMT1 VCP ANAPC4 CUL3 ATG16L1 HEATR1 SRBD1 EEF2 DNAH12 MEPCE CSTF3 DYNC1LI1 HAGH PRLR CUX1 GABPA | 1.24e-05 | 888 | 218 | 25 | int:PPIA |
| Interaction | VCP interactions | UBA5 SPAST ESS2 PSMD1 TNIP1 LRRC59 NEB RXRA ADH5 ACSL3 RAB10 GABARAPL1 BRCA1 PIK3C2B DDX54 MKI67 CLN6 PRMT1 VCP SYNCRIP CUL3 ATG16L1 RELCH ASRGL1 MAP7D3 GNE HEATR1 ARMCX3 ACTR1A HAUS1 MEPCE DYNC1LI1 ZFR PRMT3 | 1.27e-05 | 1435 | 218 | 34 | int:VCP |
| Interaction | YWHAZ interactions | TNIP1 NEB CDK14 MAST2 FSIP2 BRCA1 PIK3C2B SYNE2 MAP3K10 PRMT1 PLEKHA7 CNP ARHGEF6 VCP CUL3 ATG16L1 MAP7D3 CEP162 LCP2 MADD KIAA1671 PPP2R5C ARRB1 TIAM1 ASXL3 MEPCE OTUD4 DYNC1LI1 PLEKHA1 MAP2K2 PRLR DMTN | 1.48e-05 | 1319 | 218 | 32 | int:YWHAZ |
| Interaction | HNRNPUL2 interactions | ESS2 PSMD1 TNIP1 BRCA1 RHOBTB2 MKI67 PRMT1 VCP SYNCRIP CUL3 CCDC12 MEPCE ZFR | 1.82e-05 | 291 | 218 | 13 | int:HNRNPUL2 |
| Interaction | TTN interactions | OBSCN TNIP1 NEB MAST2 BRCA1 NFYC DNAJB5 CUL3 ATG16L1 ARL4C ARRB1 EBLN1 MEPCE | 2.42e-05 | 299 | 218 | 13 | int:TTN |
| Interaction | HEATR6 interactions | 2.46e-05 | 109 | 218 | 8 | int:HEATR6 | |
| Interaction | SUMO2 interactions | ILK TNIP1 RCC1 MAST2 BRCA1 AHNAK MKI67 RNF216 VCP SYNCRIP CUL3 ATG16L1 KALRN EEF2 TPX2 SNRNP200 ZMYM3 CUX1 AHNAK2 | 2.47e-05 | 591 | 218 | 19 | int:SUMO2 |
| Interaction | DYRK1A interactions | TSPYL2 EVPL CTTNBP2NL POM121 BRCA1 AHNAK MKI67 RNF216 DOCK6 ANAPC4 CUL3 NTPCR TRIOBP PPL ACTR1A SPATS2L TPX2 AHNAK2 | 3.38e-05 | 552 | 218 | 18 | int:DYRK1A |
| Interaction | SQSTM1 interactions | EARS2 TNIP1 LRRC59 RXRA AXIN1 ACSL3 RAB10 GABARAPL1 BRCA1 PIK3C2B AHNAK GOLGA1 SDC4 CNP VCP SYNCRIP CUL3 ATG16L1 MAP7D3 MRPL13 KIAA1671 ACTR1A EEF2 SPATS2L MAP4K5 TPX2 OTUD4 CSTF3 DYNC1LI1 ZFR | 3.82e-05 | 1257 | 218 | 30 | int:SQSTM1 |
| Interaction | YWHAB interactions | NEB CDK14 MAST2 PIK3C2B MAP3K10 PRMT1 PLEKHA7 VCP CUL3 ATG16L1 CAMKK1 MAP7D3 CEP162 KIAA1671 ACTR1A PPP2R5C ARRB1 TIAM1 MEPCE DYNC1LI1 PLEKHA1 STK38L MAP2K2 SNRNP200 DMTN AHNAK2 | 4.06e-05 | 1014 | 218 | 26 | int:YWHAB |
| Interaction | HMCN2 interactions | 4.23e-05 | 7 | 218 | 3 | int:HMCN2 | |
| Interaction | HSP90AB1 interactions | DDX59 ILK PSMD1 TNIP1 NEB CTTNBP2NL SPDL1 GABARAPL1 BRCA1 PRRC2C AHNAK RHOBTB2 MAP3K10 PRMT1 VCP SYNCRIP CUL3 ATG16L1 RBBP8 KIAA1671 EEF2 SLC34A1 ASXL3 MEPCE MAP2K2 | 4.49e-05 | 960 | 218 | 25 | int:HSP90AB1 |
| Interaction | ZNF350 interactions | 4.54e-05 | 19 | 218 | 4 | int:ZNF350 | |
| Interaction | GAPDH interactions | SPAST OBSCN TNIP1 RCC1 SPDL1 BRCA1 PRRC2C NFYC PRMT1 VCP SYNCRIP CUL3 ATG16L1 GAS7 EEF2 DNAH12 ASXL3 TET1 MEPCE CSTF3 | 5.95e-05 | 686 | 218 | 20 | int:GAPDH |
| Interaction | CAPZB interactions | SPAST TNIP1 LRRC59 ADH5 RTKN2 POLR3D BRCA1 PRRC2C RHOBTB2 MKI67 NFYC PRMT1 ARHGEF6 VCP SYNCRIP CUL3 PPP1R9A SH3KBP1 KIAA1671 ACTR1A EEF2 MEPCE DYNC1LI1 ANO7 PRMT3 CABIN1 | 7.11e-05 | 1049 | 218 | 26 | int:CAPZB |
| Interaction | H2BC21 interactions | OBSCN TNIP1 RCC1 NEB CDK14 WIZ BRCA1 AHNAK MKI67 LMNTD1 ANAPC4 NAA16 CUL3 PARP3 IYD SRBD1 TET1 TPX2 MEPCE ZMYM3 | 7.25e-05 | 696 | 218 | 20 | int:H2BC21 |
| Interaction | TOP1 interactions | WDR33 TNIP1 LRRC59 CDK14 BRCA1 RHOBTB2 MKI67 NFYC PRMT1 VCP SYNCRIP CUL3 ATG16L1 CCDC12 TIAM1 ASXL3 MEPCE CSTF3 ZFR SNRNP200 | 7.25e-05 | 696 | 218 | 20 | int:TOP1 |
| Interaction | CACYBP interactions | ILK PRRC2C AHNAK RHOBTB2 NFYC DNAJB5 ATG16L1 ACTR1A EEF2 MAP4K5 ASXL3 OTUD4 | 7.49e-05 | 288 | 218 | 12 | int:CACYBP |
| Interaction | FAF1 interactions | UBR1 ILK TNIP1 RCC1 DDX54 VCP SYNCRIP CUL3 EEF2 PPP2R5C MEPCE CSTF3 PRMT3 | 7.53e-05 | 334 | 218 | 13 | int:FAF1 |
| Interaction | CDC37 interactions | ILK TNIP1 GABARAPL1 BRCA1 RHOBTB2 SYNE2 NFYC MAP3K10 PRMT1 DNAJB5 VCP CUL3 ATG16L1 GAS7 ACTR1A EEF2 MAP4K5 STK38L MAP2K2 | 7.99e-05 | 645 | 218 | 19 | int:CDC37 |
| Interaction | CEBPA interactions | SPAST ILK ESS2 RCC1 ELMO1 RAB10 WIZ BRCA1 PRRC2C DDX54 MKI67 PRMT1 VCP SYNCRIP NAA16 CUL3 NTPCR ZNF507 CCDC12 ACTR1A EEF2 TPX2 CSTF3 DYNC1LI1 ZFR SNRNP200 ZMYM3 CUX1 GABPA | 8.00e-05 | 1245 | 218 | 29 | int:CEBPA |
| Interaction | ZNF598 interactions | PSMD1 LRRC59 ACSL3 PIGR PRMT1 VCP SYNCRIP CUL3 ANKFY1 RBBP8 ACTR1A EEF2 TPX2 OTUD4 STK38L | 8.36e-05 | 435 | 218 | 15 | int:ZNF598 |
| Interaction | RPS8 interactions | PSMD1 TNIP1 LRRC59 BRCA1 PRRC2C DDX54 MKI67 PRMT1 UTP3 VCP SYNCRIP CUL3 MRPL13 MRPL28 ARRB1 SPATS2L MEPCE ZFR MRPL40 | 8.66e-05 | 649 | 218 | 19 | int:RPS8 |
| Interaction | TSPYL6 interactions | 9.36e-05 | 68 | 218 | 6 | int:TSPYL6 | |
| Interaction | NSMCE2 interactions | 9.74e-05 | 43 | 218 | 5 | int:NSMCE2 | |
| Interaction | ISG15 interactions | SPAST WDR33 PSMD1 LRRC59 PRRC2C AHNAK DDX54 DNAJB5 VCP GTF2IRD1 EEF2 SPATS2L HELZ2 MEPCE SNRNP200 AHNAK2 | 1.01e-04 | 494 | 218 | 16 | int:ISG15 |
| Interaction | RIPK4 interactions | SPAST ILK ESS2 RCC1 LRRC59 DDX54 CLN6 SDC4 CNP VCP NAA16 MAP7D3 NTPCR ZNF507 MADD | 1.10e-04 | 446 | 218 | 15 | int:RIPK4 |
| Interaction | COPS2 interactions | RXRA AXIN1 RHOBTB2 PLAAT2 MAP3K10 ANAPC4 CUL3 LRR1 SEPHS1 DYNC1LI1 SNRNP200 | 1.22e-04 | 258 | 218 | 11 | int:COPS2 |
| Interaction | BCAR1 interactions | ESS2 EARS2 TNIP1 POLR3D WIZ UTP3 METTL16 VCP GNE SH3KBP1 NSMCE2 ARMCX3 SEPHS1 HAUS1 SLC34A1 MEPCE HAGH | 1.23e-04 | 556 | 218 | 17 | int:BCAR1 |
| Interaction | CLTA interactions | SPAST PSMD1 TNIP1 DNAJB5 CFAP97 VCP CUL3 ATG16L1 KIAA1671 ARRB1 ITSN2 MEPCE AHNAK2 | 1.24e-04 | 351 | 218 | 13 | int:CLTA |
| Interaction | H3C1 interactions | TSPYL2 TNIP1 RCC1 LRRC59 NEB SPDL1 WIZ PRRC2C AHNAK DDX54 MKI67 PRMT1 UTP3 MRPL28 SRBD1 DNAH1 SPATS2L TPX2 MEPCE CSTF3 ZFR CABIN1 CUX1 | 1.24e-04 | 901 | 218 | 23 | int:H3C1 |
| Interaction | NUP107 interactions | 1.53e-04 | 221 | 218 | 10 | int:NUP107 | |
| Interaction | BAG2 interactions | ILK ESS2 VPS13C TNIP1 WIZ PRRC2C AHNAK NFYC DNAJB5 RMC1 VCP CUL3 ARRDC4 KIAA1671 TPX2 OTUD4 CSTF3 MAP2K2 | 1.54e-04 | 622 | 218 | 18 | int:BAG2 |
| Interaction | TRIM27 interactions | ILK AXIN1 POM121 BRCA1 PIK3C2B NFYC CUL3 ATG16L1 GNE CEP162 PPL EEF2 HAUS1 MRPL40 PAX7 STK38L | 1.59e-04 | 514 | 218 | 16 | int:TRIM27 |
| Interaction | MOV10 interactions | DDX59 ILK OBSCN PSMD1 TNIP1 RCC1 LRRC59 RNF150 GABARAPL1 BRCA1 PRRC2C MKI67 RNF216 PRMT1 CFAP97 SYNCRIP CUL3 ATG16L1 MAP7D3 SH3KBP1 MRPL13 KIAA1671 ACTR1A MEPCE OTUD4 ZFR SNRNP200 ZMYM3 DMTN | 1.62e-04 | 1297 | 218 | 29 | int:MOV10 |
| Interaction | CSNK2B interactions | SPAST TSPYL2 LRRC59 RXRA ADH5 WIZ BRCA1 DDX54 PRMT1 UTP3 CFAP97 VCP CUL3 ATG16L1 SH3KBP1 MADD CTDP1 MEPCE | 1.63e-04 | 625 | 218 | 18 | int:CSNK2B |
| Interaction | NUP43 interactions | SPAST TSPYL2 TASOR2 FSIP2 POM121 BRCA1 PRRC2C SYNE2 MKI67 UTP3 ANAPC4 ATG16L1 RBBP8 HEATR1 SNRNP200 ZMYM3 GABPA AHNAK2 | 1.63e-04 | 625 | 218 | 18 | int:NUP43 |
| Interaction | YWHAQ interactions | PSMD1 NEB CDK14 MAST2 BRCA1 PIK3C2B MAP3K10 PRMT1 PLEKHA7 VCP CUL3 CACNA1S ATG16L1 CAMKK1 MAP7D3 CEP162 KIAA1671 EEF2 ARRB1 TIAM1 TET1 MEPCE PLEKHA1 CABIN1 MAP2K2 DMTN | 1.97e-04 | 1118 | 218 | 26 | int:YWHAQ |
| Interaction | BRCA1 interactions | UBR1 ILK OBSCN PSMD1 LRRC59 RTKN2 POM121 WIZ BRCA1 AHNAK DDX54 MKI67 RNF216 PRMT1 LMNTD1 VCP ANAPC4 SYNCRIP RBBP8 NSMCE2 GTF2IRD1 EEF2 PPP2R5C TPX2 ZFR CABIN1 SNRNP200 ZMYM3 | 2.03e-04 | 1249 | 218 | 28 | int:BRCA1 |
| Interaction | YBX1 interactions | TNIP1 LRRC59 SPDL1 BRCA1 DDX54 PRMT1 VCP SYNCRIP CUL3 ATG16L1 MRPL13 MRPL28 LCP2 EEF2 ARRB1 ASXL3 MEPCE ZFR MRPL40 SNRNP200 | 2.04e-04 | 752 | 218 | 20 | int:YBX1 |
| Interaction | PML interactions | ESS2 TSPYL2 CTTNBP2NL RXRA AXIN1 BRCA1 PIGR AHNAK SYNE2 RNF216 PRMT1 VCP SYNCRIP CUL3 ANKFY1 NTPCR HEATR1 NSMCE2 ARMCX3 EEF2 SPATS2L ZMYM3 AHNAK2 | 2.06e-04 | 933 | 218 | 23 | int:PML |
| Interaction | ERC1 interactions | 2.07e-04 | 187 | 218 | 9 | int:ERC1 | |
| Interaction | RPS6 interactions | SPAST TNIP1 LRRC59 WIZ BRCA1 DDX54 MKI67 PRMT1 UTP3 VCP SYNCRIP CUL3 MRPL13 MRPL28 HEATR1 EEF2 SPATS2L TPX2 MEPCE ZFR MRPL40 HAGH | 2.13e-04 | 874 | 218 | 22 | int:RPS6 |
| Interaction | FBL interactions | TNIP1 WIZ BRCA1 PRRC2C DDX54 MKI67 PRMT1 POLR1B UTP3 SYNCRIP CUL3 HEATR1 ARMCX3 SPATS2L MEPCE OTUD4 ZFR PRMT3 | 2.14e-04 | 639 | 218 | 18 | int:FBL |
| Interaction | OPTN interactions | LYRM7 DDX59 TNIP1 CMYA5 NEB RAB10 GABARAPL1 SYNE2 MKI67 RNF216 SDC4 VCP ATG16L1 ARMCX3 | 2.15e-04 | 422 | 218 | 14 | int:OPTN |
| Interaction | HSF2 interactions | 2.15e-04 | 79 | 218 | 6 | int:HSF2 | |
| Interaction | USB1 interactions | 2.22e-04 | 51 | 218 | 5 | int:USB1 | |
| Interaction | YWHAE interactions | TNIP1 CDK14 MAST2 BRCA1 PIK3C2B DDX54 MAP3K10 PRMT1 PLEKHA7 VCP CUL3 ATG16L1 CAMKK1 MAP7D3 LCP2 KIAA1671 ACTR1A FRMD4A PPP2R5C ARRB1 TIAM1 TET1 MEPCE DYNC1LI1 PLEKHA1 STK38L MAP2K2 DMTN | 2.23e-04 | 1256 | 218 | 28 | int:YWHAE |
| Interaction | AP2B1 interactions | PSMD1 TNIP1 POM121 BRCA1 MKI67 AGFG2 VCP CUL3 ATG16L1 KIAA1671 ARRB1 ITSN2 ANO7 | 2.24e-04 | 373 | 218 | 13 | int:AP2B1 |
| Interaction | H2AC17 interactions | WIZ DDX54 CRAMP1 MRPL13 MRPL28 SRBD1 SPATS2L TPX2 HELZ2 MRPL40 | 2.27e-04 | 232 | 218 | 10 | int:H2AC17 |
| Interaction | LAMP1 interactions | ILK TMEM237 KIAA0319L LRRC59 ACSL3 RAB10 PLCB1 PLD1 CNP VCP RELCH PPP1R9A TRIOBP TIAM1 ITSN2 PLEKHA1 CUX1 AHNAK2 | 2.35e-04 | 644 | 218 | 18 | int:LAMP1 |
| Interaction | STIP1 interactions | UBA5 DDX59 ILK PSMD1 LRRC59 NEB ADH5 BRCA1 AHNAK DNAJB5 CNP VCP SYNCRIP ANKFY1 NTPCR HEATR1 ACTR1A EEF2 OTUD4 CSTF3 DYNC1LI1 PRMT3 MAP2K2 SNRNP200 | 2.42e-04 | 1006 | 218 | 24 | int:STIP1 |
| Interaction | PABPN1 interactions | 2.52e-04 | 192 | 218 | 9 | int:PABPN1 | |
| Interaction | RTKN2 interactions | 2.56e-04 | 12 | 218 | 3 | int:RTKN2 | |
| Interaction | DNAH3 interactions | 2.56e-04 | 12 | 218 | 3 | int:DNAH3 | |
| Interaction | FXR2 interactions | TNIP1 AXIN1 POM121 BRCA1 PRRC2C DDX54 MKI67 CUL3 RBBP8 TRIOBP LCP2 KIAA1671 EEF2 OTUD4 | 2.60e-04 | 430 | 218 | 14 | int:FXR2 |
| Interaction | AATK interactions | 2.72e-04 | 194 | 218 | 9 | int:AATK | |
| Interaction | ARFGEF3 interactions | 2.82e-04 | 83 | 218 | 6 | int:ARFGEF3 | |
| Interaction | EEF1D interactions | TNIP1 SPDL1 BRCA1 AHNAK PRMT1 VCP CUL3 ATG16L1 ASXL3 USP40 MEPCE SNRNP200 | 2.89e-04 | 333 | 218 | 12 | int:EEF1D |
| Interaction | SMURF1 interactions | CDK14 AXIN1 RAB10 DDX54 MKI67 MAP3K10 PRMT1 VCP SYNCRIP NAA16 ANKFY1 KIAA1671 ACTR1A EEF2 MAP4K5 STK38L | 3.00e-04 | 544 | 218 | 16 | int:SMURF1 |
| Interaction | ADH1B interactions | 3.30e-04 | 13 | 218 | 3 | int:ADH1B | |
| Interaction | RCOR1 interactions | PSMD1 TNIP1 SPDL1 AHNAK MKI67 PRMT1 VCP CUL3 ANKFY1 RBBP8 ACTR1A TET1 PAX7 ZMYM3 CUX1 | 3.31e-04 | 494 | 218 | 15 | int:RCOR1 |
| Interaction | ITPRID2 interactions | 3.33e-04 | 120 | 218 | 7 | int:ITPRID2 | |
| Interaction | EFHB interactions | 3.47e-04 | 3 | 218 | 2 | int:EFHB | |
| Interaction | TERF2IP interactions | ESS2 WDR33 TASOR2 WIZ BRCA1 MKI67 ANAPC4 CUL3 ZNF507 PRX ARL4C TPX2 MEPCE HAGH ZMYM3 CUX1 | 3.52e-04 | 552 | 218 | 16 | int:TERF2IP |
| Interaction | YLPM1 interactions | 3.60e-04 | 160 | 218 | 8 | int:YLPM1 | |
| Interaction | HNRNPU interactions | TNIP1 SPDL1 BRCA1 DDX54 PRMT1 SYNCRIP NAA16 CUL3 MRPL13 GAS7 MRPL28 SRBD1 DNAH1 ACTR1A ARRB1 SPATS2L MAP4K5 ASXL3 TPX2 MEPCE ZFR MRPL40 SNRNP200 HYDIN | 3.67e-04 | 1035 | 218 | 24 | int:HNRNPU |
| Interaction | HNRNPCL1 interactions | 3.76e-04 | 161 | 218 | 8 | int:HNRNPCL1 | |
| Interaction | NR3C1 interactions | UBR1 PLVAP NEB ACSL3 RAB10 SYNE2 DDX54 PLCB1 CUL3 ATG16L1 ANKFY1 MAP7D3 NTPCR MRPL28 LRR1 ARRB1 DNAH12 ASXL3 ITSN2 OTUD4 MAP2K2 CUX1 AHNAK2 | 3.79e-04 | 974 | 218 | 23 | int:NR3C1 |
| Interaction | KPNA3 interactions | RCC1 POM121 BRCA1 CUL3 ATG16L1 GTF2IRD1 ACTR1A ARRB1 MEPCE SNRNP200 | 3.86e-04 | 248 | 218 | 10 | int:KPNA3 |
| Interaction | COPS7A interactions | 3.92e-04 | 162 | 218 | 8 | int:COPS7A | |
| Interaction | DHX40 interactions | ESS2 WDR33 TASOR2 SPDL1 BRCA1 DDX54 UTP3 ATG16L1 MEPCE SNRNP200 | 3.98e-04 | 249 | 218 | 10 | int:DHX40 |
| Interaction | HDAC1 interactions | PSMD1 TNIP1 SPDL1 ADH5 WIZ BRCA1 AHNAK SYNE2 MKI67 NFYC PRMT1 CUL3 ATG16L1 ANKFY1 RBBP8 ZNF507 KIAA1671 ACTR1A BCL11B TET1 PRMT3 CABIN1 ZMYM3 CUX1 GABPA | 4.13e-04 | 1108 | 218 | 25 | int:HDAC1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 3.05e-05 | 37 | 221 | 4 | chr4q23 | |
| Cytoband | 4q23 | 1.18e-04 | 20 | 221 | 3 | 4q23 | |
| Cytoband | 2q37.1 | 3.16e-04 | 67 | 221 | 4 | 2q37.1 | |
| Cytoband | 9p13.3 | 4.86e-04 | 75 | 221 | 4 | 9p13.3 | |
| GeneFamily | Alcohol dehydrogenases | 3.02e-07 | 8 | 149 | 4 | 397 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | PSD RTKN2 PLD1 PLEKHA7 ARHGEF6 RASA3 TRIOBP TIAM1 ARHGAP12 PLEKHA1 | 8.18e-06 | 206 | 149 | 10 | 682 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.12e-04 | 66 | 149 | 5 | 722 | |
| GeneFamily | PDZ domain containing | 2.68e-04 | 152 | 149 | 7 | 1220 | |
| GeneFamily | Dyneins, axonemal | 3.43e-04 | 17 | 149 | 3 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.82e-04 | 19 | 149 | 3 | 832 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 6.64e-04 | 5 | 149 | 2 | 1336 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.83e-03 | 8 | 149 | 2 | 939 | |
| GeneFamily | CTD family phosphatases | 1.83e-03 | 8 | 149 | 2 | 1041 | |
| GeneFamily | Protein arginine methyltransferases | 2.34e-03 | 9 | 149 | 2 | 691 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_4H_BMDC_DN | 7.62e-06 | 200 | 219 | 10 | M3942 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 7.62e-06 | 200 | 219 | 10 | M6252 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 4.27e-05 | 196 | 219 | 9 | M7664 | |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | AHNAK RNF216 POLR1B UTP3 POLE4 EPG5 PPP2R5C KIAA0825 CCDC180 | 4.62e-05 | 198 | 219 | 9 | M8131 |
| Coexpression | GSE25087_FETAL_VS_ADULT_TREG_UP | 4.62e-05 | 198 | 219 | 9 | M4641 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN | 4.80e-05 | 199 | 219 | 9 | M4188 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 4.99e-05 | 200 | 219 | 9 | M4617 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 4.99e-05 | 200 | 219 | 9 | M6687 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | TSPYL2 TXK PRRC2C SYNE2 ARL4C EEF2 PPP2R5C BCL11B PLXNA4 PLEKHA1 | 2.21e-08 | 178 | 221 | 10 | 73936c2e7e8855b4ab65cad425686513dba331a3 |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | PLVAP CTTNBP2NL ELMO1 PIK3C2B SYNE2 PLCB1 DOCK6 ASRGL1 KALRN KIAA1671 | 4.31e-08 | 191 | 221 | 10 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.12e-07 | 160 | 221 | 9 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-07 | 164 | 221 | 9 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-07 | 164 | 221 | 9 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-07 | 169 | 221 | 9 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 2.18e-07 | 173 | 221 | 9 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-07 | 175 | 221 | 9 | f456d8d958b71f7a942b718605712593d9de1bfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-07 | 185 | 221 | 9 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | CTTNBP2NL ELMO1 PIK3C2B SYNE2 PLCB1 PLCB4 ASRGL1 KIAA1671 MMRN2 | 4.21e-07 | 187 | 221 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 4.60e-07 | 189 | 221 | 9 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | PLVAP CTTNBP2NL ELMO1 PIK3C2B SYNE2 DOCK6 ASRGL1 KALRN KIAA1671 | 5.25e-07 | 192 | 221 | 9 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.51e-07 | 197 | 221 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.79e-07 | 198 | 221 | 9 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.79e-07 | 198 | 221 | 9 | db107a5511571384f26e26c6301aef9a9f2423c4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 7.09e-07 | 199 | 221 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | VPS13C GABARAPL1 SYNE2 CFAP97 ABCC9 SPATS2L ITSN2 PLEKHA1 AHNAK2 | 7.09e-07 | 199 | 221 | 9 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.39e-07 | 200 | 221 | 9 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.39e-07 | 200 | 221 | 9 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.39e-07 | 200 | 221 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-07 | 149 | 221 | 8 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 155 | 221 | 8 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 155 | 221 | 8 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-06 | 156 | 221 | 8 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.47e-06 | 161 | 221 | 8 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 162 | 221 | 8 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 162 | 221 | 8 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 163 | 221 | 8 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 163 | 221 | 8 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 164 | 221 | 8 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-06 | 166 | 221 | 8 | 9fae71b0a42a9b2222453c03e0a1e83f30117ae9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 168 | 221 | 8 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | CTTNBP2NL RNF150 ALOX15 FBXW10 FRMD4A SPATS2L CCDC74A BTBD19 | 2.98e-06 | 177 | 221 | 8 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.98e-06 | 184 | 221 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 4.14e-06 | 185 | 221 | 8 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-06 | 185 | 221 | 8 | 45890fa81c65a48f4fdec164a4c8d0e2831243c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-06 | 185 | 221 | 8 | 585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 4.14e-06 | 185 | 221 | 8 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.31e-06 | 186 | 221 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-06 | 186 | 221 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.31e-06 | 186 | 221 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-06 | 187 | 221 | 8 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 4.66e-06 | 188 | 221 | 8 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 190 | 221 | 8 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 190 | 221 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.04e-06 | 190 | 221 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.10e-06 | 135 | 221 | 7 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 191 | 221 | 8 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-06 | 194 | 221 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.09e-06 | 195 | 221 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.09e-06 | 195 | 221 | 8 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.09e-06 | 195 | 221 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.33e-06 | 196 | 221 | 8 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.33e-06 | 196 | 221 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.33e-06 | 196 | 221 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 6.33e-06 | 196 | 221 | 8 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.57e-06 | 197 | 221 | 8 | 51340570667914bffec741c72a8d09cc46abb8e8 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.57e-06 | 197 | 221 | 8 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | mLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype | 6.57e-06 | 197 | 221 | 8 | 5c781ded147db2f3804ee1f21ef0898c4f354890 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-06 | 197 | 221 | 8 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 197 | 221 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mLN-T_cell-gd_T|mLN / Region, Cell class and subclass | 6.57e-06 | 197 | 221 | 8 | 8ef03bdbd34a874671aebfdbb7111106aa37b2a9 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 6.82e-06 | 198 | 221 | 8 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 6.82e-06 | 198 | 221 | 8 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.82e-06 | 198 | 221 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.82e-06 | 198 | 221 | 8 | 41ead3d3733b79e3e45648d5ce1909e617c35ed7 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.82e-06 | 198 | 221 | 8 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.82e-06 | 198 | 221 | 8 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-06 | 199 | 221 | 8 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-06 | 199 | 221 | 8 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-06 | 199 | 221 | 8 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-06 | 199 | 221 | 8 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-06 | 199 | 221 | 8 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T|Leuk-UTI / Disease, condition lineage and cell class | 7.07e-06 | 199 | 221 | 8 | b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.33e-06 | 200 | 221 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.33e-06 | 200 | 221 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 149 | 221 | 7 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-05 | 151 | 221 | 7 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 151 | 221 | 7 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 151 | 221 | 7 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 221 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 221 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 221 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 154 | 221 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-05 | 154 | 221 | 7 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 159 | 221 | 7 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 164 | 221 | 7 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-05 | 167 | 221 | 7 | b5d15773be32cd277125fd3b4056a8fefaefa5ec | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 167 | 221 | 7 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-05 | 168 | 221 | 7 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 169 | 221 | 7 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 171 | 221 | 7 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-05 | 174 | 221 | 7 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| Drug | 2-NA | 9.92e-07 | 9 | 218 | 4 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 9.92e-07 | 9 | 218 | 4 | CID000440672 | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; HL60; HT_HG-U133A | WDR33 MAST2 AXIN1 GABARAPL1 PIK3C2B PLCL2 AGFG2 PLCB4 GOLGA1 RASA3 ARHGAP12 | 3.17e-06 | 196 | 218 | 11 | 1333_UP |
| Drug | AC1L1J0I | 3.81e-06 | 12 | 218 | 4 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 3.81e-06 | 12 | 218 | 4 | CID000008104 | |
| Drug | 2-naphthaldehyde | 5.46e-06 | 13 | 218 | 4 | CID000006201 | |
| Drug | naphthalenemethanol | 7.59e-06 | 14 | 218 | 4 | CID000020908 | |
| Drug | AC1L1AOQ | 9.01e-06 | 30 | 218 | 5 | CID000001082 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.03e-05 | 15 | 218 | 4 | CID000440673 | |
| Drug | willardine | 1.25e-05 | 32 | 218 | 5 | CID000005123 | |
| Drug | naphthaldehyde | 1.36e-05 | 16 | 218 | 4 | CID000006195 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.79e-05 | 193 | 218 | 10 | 3412_DN | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 1.87e-05 | 194 | 218 | 10 | 1147_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 6605_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 3217_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; HL60; HG-U133A | 2.14e-05 | 197 | 218 | 10 | 1713_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 5996_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | MYL4 KIAA0319L CHM AXIN1 POLR3D DLX2 ANKFY1 CTDP1 CABIN1 DMTN | 2.33e-05 | 199 | 218 | 10 | 4297_DN |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.33e-05 | 199 | 218 | 10 | 5309_DN | |
| Disease | Malignant neoplasm of breast | DDX59 SPAST ATP7B OBSCN TNIP1 BRCA1 SYNE2 MKI67 NFYC PLCB1 KALRN ZSWIM5 MRPL13 NSMCE2 UBLCP1 PCDH20 EPG5 EEF2 ITSN2 DIP2C CUX1 | 3.98e-05 | 1074 | 214 | 21 | C0006142 |
| Disease | Mouth Neoplasms | 4.54e-05 | 54 | 214 | 5 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 4.54e-05 | 54 | 214 | 5 | C0153381 | |
| Disease | cognitive function measurement | GABRG3 TNIP1 RXRA PRRC2C PLCL2 PLCB1 RNF216 LMNTD1 ANAPC4 CUL3 ANKFY1 KALRN TRIOBP FRMD4A BCL11B SPATS2L ITSN2 PLXNA4 PLEKHA1 ZFR PRMT3 HYDIN PRLR GABPA | 1.26e-04 | 1434 | 214 | 24 | EFO_0008354 |
| Disease | Colorectal Carcinoma | ATP7B OBSCN NPAP1 MKI67 ANAPC4 RELCH DNAH3 KALRN BCL11B TIAM1 TPX2 MMRN2 DIP2C SNRNP200 CUX1 | 2.04e-04 | 702 | 214 | 15 | C0009402 |
| Disease | ANGPTL8 measurement | 3.11e-04 | 4 | 214 | 2 | EFO_0020861 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 3.35e-04 | 19 | 214 | 3 | EFO_0000220, GO_0097327 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 5.16e-04 | 5 | 214 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 6.80e-04 | 24 | 214 | 3 | EFO_0009458, MONDO_0007079 | |
| Disease | contactin-1 measurement | 7.70e-04 | 6 | 214 | 2 | EFO_0020286 | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 7.70e-04 | 6 | 214 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 9.68e-04 | 27 | 214 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | hematocrit | IRAG1 MAST2 RXRA ADH1C ADH7 PLCL2 PLCB1 AGFG2 ANKFY1 KALRN NTPCR CCDC12 FRMD4A BCL11B SLC34A1 MAP4K5 HYDIN | 1.19e-03 | 1011 | 214 | 17 | EFO_0004348 |
| Disease | Ischemic stroke, factor VII measurement | 1.20e-03 | 29 | 214 | 3 | EFO_0004619, HP_0002140 | |
| Disease | Headache | 1.22e-03 | 64 | 214 | 4 | HP_0002315 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.37e-03 | 112 | 214 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.42e-03 | 8 | 214 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 1.42e-03 | 8 | 214 | 2 | EFO_0802066 | |
| Disease | X-17676 measurement | 1.42e-03 | 8 | 214 | 2 | EFO_0800785 | |
| Disease | Endometrial Carcinoma | 1.88e-03 | 72 | 214 | 4 | C0476089 | |
| Disease | urate measurement, bone density | DDX59 FSIP2 RHOBTB2 PLCB1 PPL DNAH1 BCL11B MAP4K5 USP40 HELZ2 PLXNA4 CABIN1 | 1.99e-03 | 619 | 214 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Major Depressive Disorder | 2.06e-03 | 243 | 214 | 7 | C1269683 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 2.44e-03 | 37 | 214 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | parasitemia measurement | 2.44e-03 | 37 | 214 | 3 | EFO_0005528 | |
| Disease | venous thromboembolism, factor VII measurement | 2.63e-03 | 38 | 214 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | neutrophil count | TAGAP CYP3A5 WDR33 MAST2 CTTNBP2NL SAMD15 BRCA1 PLCB1 PLCB4 RMC1 DOCK6 RBBP8 CCDC12 NSMCE2 ACTR1A BCL11B MAP4K5 ITSN2 STK38L HYDIN | 2.68e-03 | 1382 | 214 | 20 | EFO_0004833 |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 2.76e-03 | 11 | 214 | 2 | OBA_2045176 | |
| Disease | level of Ceramide (d40:1) in blood serum | 2.76e-03 | 11 | 214 | 2 | OBA_2045185 | |
| Disease | eotaxin measurement | 2.77e-03 | 80 | 214 | 4 | EFO_0008122 | |
| Disease | monocyte percentage of leukocytes | PLVAP WIZ BRCA1 AHNAK PLCB1 RMC1 MADD DNAH12 EBLN1 MAP4K5 ITSN2 TPX2 CTDP1 | 2.77e-03 | 731 | 214 | 13 | EFO_0007989 |
| Disease | eosinophil count | MYL4 TNIP1 SAMD15 ELMO1 ADH7 BRCA1 PIK3C2B PLCL2 POLR1B PLD1 ALOX15 DNAH3 RBBP8 NSMCE2 LCP2 HAUS1 MAP4K5 HELZ2 MAP2K2 SNRNP200 CUX1 | 2.83e-03 | 1488 | 214 | 21 | EFO_0004842 |
| Disease | lactate measurement | 2.84e-03 | 39 | 214 | 3 | EFO_0007745 | |
| Disease | lung cancer (is_marker_for) | 2.84e-03 | 39 | 214 | 3 | DOID:1324 (is_marker_for) | |
| Disease | Unipolar Depression | 2.94e-03 | 259 | 214 | 7 | C0041696 | |
| Disease | alpha-hydroxybutyric acid measurement | 3.29e-03 | 12 | 214 | 2 | EFO_0010458 | |
| Disease | Congenital myopathy (disorder) | 3.29e-03 | 12 | 214 | 2 | C0270960 | |
| Disease | bitter beverage consumption measurement | 3.51e-03 | 42 | 214 | 3 | EFO_0010089 | |
| Disease | stomach cancer (is_marker_for) | 3.84e-03 | 142 | 214 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Benign tumor of pancreas | 3.87e-03 | 13 | 214 | 2 | C0347284 | |
| Disease | Sjogren's Syndrome | 3.87e-03 | 13 | 214 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 3.87e-03 | 13 | 214 | 2 | C0086981 | |
| Disease | platelet aggregation | 4.27e-03 | 45 | 214 | 3 | GO_0070527 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 4.50e-03 | 14 | 214 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | sulfate measurement | 4.50e-03 | 14 | 214 | 2 | EFO_0007864 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 5.07e-03 | 216 | 214 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | bilirubin measurement | 5.20e-03 | 442 | 214 | 9 | EFO_0004570 | |
| Disease | glaucoma | 5.41e-03 | 154 | 214 | 5 | MONDO_0005041 | |
| Disease | testosterone measurement | UBR1 RXRA ADH5 SYNE2 PLCB1 AGFG2 METTL16 ARHGEF6 ANAPC4 CCDC12 GTF2IRD1 RIC8B BCL11B SLC34A1 MAP4K5 MYOCD ARID3C PRLR | 5.58e-03 | 1275 | 214 | 18 | EFO_0004908 |
| Disease | RS-10-hydroxywarfarin measurement | 5.71e-03 | 98 | 214 | 4 | EFO_0803330 | |
| Disease | diastolic blood pressure, body mass index | 5.88e-03 | 16 | 214 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | cutaneous psoriasis measurement, psoriasis | 5.88e-03 | 16 | 214 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 5.88e-03 | 16 | 214 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | filaggrin gene expression measurement | 5.88e-03 | 16 | 214 | 2 | EFO_0020899 | |
| Disease | substance-related disorder | 6.40e-03 | 52 | 214 | 3 | MONDO_0002494 | |
| Disease | phospholipids:total lipids ratio | 6.42e-03 | 227 | 214 | 6 | EFO_0020946 | |
| Disease | esophageal carcinoma, gastric carcinoma | 6.63e-03 | 17 | 214 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | high altitude adaptation | 6.63e-03 | 17 | 214 | 2 | EFO_0009105 | |
| Disease | protein C measurement | 6.63e-03 | 17 | 214 | 2 | EFO_0004633 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPSNKIVKRAEELV | 86 | Q9NWW9 | |
| KIVKRAEELVGQELP | 91 | Q9NWW9 | |
| IEEIEVAPPKTKEVR | 36 | P40394 | |
| QVPPREKSVALAQEK | 371 | Q9P2B4 | |
| IEELKAEVRLLKGPP | 696 | Q96CN4 | |
| IEEAPDIRKIVPELK | 616 | Q9Y5B0 | |
| ELVPFTKEQLKILEP | 251 | Q9HCE0 | |
| DNIPADIVFVLKDKP | 236 | O75953 | |
| RPILELKEKIQPEIL | 531 | Q92556 | |
| RKDSIPQVLLPEEEK | 681 | Q15052 | |
| LAPEIVIKVEKLDPE | 791 | Q9UJX5 | |
| LPKSLPVAEIEKQLA | 131 | P56559 | |
| IPNRIPKIVKEGEDD | 116 | Q9P2B7 | |
| QIKEENAVFKIPLRP | 576 | Q99708 | |
| EVEVAPPKAHEVRIK | 26 | P07327 | |
| EVAPPKAHEVRIKII | 26 | P11766 | |
| EKLAPEEPPEKRAVL | 311 | A6NKF2 | |
| VPEIPGEKLVTERNK | 131 | Q7L266 | |
| VKFDPEIIGPRDIIK | 606 | P35670 | |
| LLQPEKPIVLKVDSR | 481 | P20815 | |
| KPRVVLAPEEKEALK | 1246 | P39880 | |
| QKELAEAAKEPLPVE | 221 | Q676U5 | |
| EVEVAPPKAHEVRIK | 26 | P00326 | |
| PIDVKRTSIPLEIQK | 876 | Q5XX13 | |
| REIIELPLKQPELFK | 366 | Q8NB90 | |
| LINEILEEPNLDKKP | 66 | Q96NL8 | |
| PILNDDKPKDLVVLV | 441 | Q8WYK0 | |
| RDVPPADQEKLFIQK | 31 | Q13362 | |
| LPRVEGKVKVPEVDV | 591 | Q09666 | |
| VDIRGPKVDIKAPDV | 1101 | Q09666 | |
| EINIKAPKISIPDVD | 4841 | Q09666 | |
| KVKPPEDLQDLGVRF | 201 | O60706 | |
| PLDTIPEDKKVRVQR | 61 | O94921 | |
| GKPLIEDPAVDVIRK | 1246 | Q9P1Z9 | |
| VAERAILPALKQTPK | 341 | Q96AQ1 | |
| EDLEPEIRIVNGKPK | 136 | Q07687 | |
| ERIIPDPNVIKLRKE | 291 | Q9UHL0 | |
| PIVAKILNTRDPIVK | 166 | Q9UH62 | |
| PEDKKPLTRLQERLI | 91 | P49407 | |
| EKVLPQPRLGAKLEI | 1761 | Q9C0F0 | |
| AIKEPLVDVVDPKQL | 231 | Q99873 | |
| LERPKVPDQSVKREL | 146 | Q8NCT1 | |
| PRIIRDPEAQEKLIK | 286 | Q9ULI1 | |
| DQVLKEAKRIPEEIL | 156 | P36507 | |
| PIAEDTTEQPKKNRI | 201 | P24386 | |
| ERKKPALVSIPEDVV | 56 | P18754 | |
| LAEDILRKTPVKEPN | 166 | P61026 | |
| LRKTPVKEPNSENVD | 171 | P61026 | |
| PVELEPKRTIQSLKE | 976 | Q01804 | |
| RRDPKSVEQPIVLKE | 566 | Q14644 | |
| VKIIPGSEVKREEPE | 951 | Q9NZM3 | |
| PVINKIDLKNADPER | 191 | Q8N442 | |
| LKAIPAEKRIIRVDP | 36 | Q9Y6F1 | |
| PRQVATPDVEKKIEE | 106 | P23759 | |
| LVPDIPESVEIKVKR | 871 | Q6IWH7 | |
| VIEQLDKFTPKRDNP | 11 | D6REC4 | |
| EIPIIKFDLNKPVRV | 1141 | Q9P2R3 | |
| EIQEPIKPLEKRALN | 246 | Q9P260 | |
| LLRKEPEINIEEKEP | 856 | Q8N6Y1 | |
| EVAVKAARLDPEKDP | 121 | Q02779 | |
| EKQRPEVIKPVFDLG | 1136 | Q8WXG6 | |
| KIRPDNELFEVREKP | 656 | Q92805 | |
| PPKLAQEILVEVLEK | 651 | Q8IV33 | |
| VLPRDLEKEDAPQEK | 1466 | Q9BY89 | |
| AKGRDPVEILIPKDI | 221 | Q7L2J0 | |
| LENIAKTEPPKIFRV | 116 | Q8NI17 | |
| EGKATVRLKEPPVDI | 76 | Q96L50 | |
| EAREPPEKTNLKDVI | 501 | Q0VAK6 | |
| DLNEVPVKELAALPK | 26 | Q96AG4 | |
| EVKPDPRKNNLVEII | 781 | Q8IZA0 | |
| KKEAEPLVDIRVTGP | 796 | Q9H8L6 | |
| PKLNILEIVKPADTV | 106 | Q06546 | |
| VDPVQPQKVVDAARK | 76 | Q16775 | |
| ESKREVALKVLVPPN | 1881 | Q8NDA2 | |
| DKNPETRIGVPDIKL | 391 | Q8N5S9 | |
| VPLDVKLDPAVQQLK | 66 | Q6KB66 | |
| PIQRKTIPVILDGKD | 121 | Q8TDD1 | |
| EDNFEDIITKPPVRK | 346 | Q9Y6G9 | |
| VAKIIKPDPEDLQLD | 21 | Q5T1V6 | |
| SEPKPVDDINDKIIR | 1251 | Q5CZC0 | |
| IEIVFAKPPDQKRKE | 401 | O60506 | |
| PRLQKVLAKLPLAEE | 396 | Q9Y6F6 | |
| QPIDPASLEEFKRKI | 411 | Q9BX97 | |
| RVDKILVPVEVIKPI | 706 | Q9HCM2 | |
| QEKVREIVRPDPKAE | 1171 | O60437 | |
| ENPLEEAVKFLIPLK | 651 | Q6N069 | |
| SIVPVLKDEVDRKPE | 566 | Q12996 | |
| IQELEKRPPTVQEKI | 1446 | Q92817 | |
| PVPRVKLIDLEDAVQ | 2816 | O60229 | |
| LSPVKEPKLRNDLRE | 241 | Q8TC05 | |
| INHVKEERPEKIPDL | 86 | Q96MF7 | |
| EERPEKIPDLKLLVE | 91 | Q96MF7 | |
| DPKDQQRLPIFKIEL | 316 | Q6ZR08 | |
| PARGKETELKVEVPE | 41 | P16050 | |
| APLKEELRIQGVPKV | 256 | Q86W50 | |
| PRAPEDVIQALEEKK | 396 | Q86W50 | |
| QAQVLLKREKEIPPT | 311 | Q8N9Z9 | |
| VPKGKPLALVEEIRN | 146 | Q9BSD7 | |
| NAEVLRVLGKPKPEE | 91 | P12829 | |
| IVEELPASKKQRVAP | 3021 | P46013 | |
| VPELLLEKPLDREKQ | 191 | Q9Y5F7 | |
| ADLPPQKLVIVVKDS | 636 | Q9Y5F7 | |
| KIALRPGPLELVEKN | 111 | Q8IZQ8 | |
| DELKPPKRQEEVRQS | 121 | Q13952 | |
| LKLVPRKDLLVENVP | 81 | Q5U5X0 | |
| RVAAVKDLIRQLPKP | 761 | Q8IWW6 | |
| QPKIQKDPSVLAVRE | 566 | O00750 | |
| EEEQKPESRLVPKLR | 81 | Q06495 | |
| PAVPFKKRLQDLEVR | 331 | Q5VST9 | |
| QTPERPAKKIREEEL | 446 | Q96HA1 | |
| FVNPSLPREEKEEKL | 721 | P38398 | |
| PVAEVAAPVVKELRL | 211 | C9JJ37 | |
| NEVVRSDLKKLPALP | 156 | Q9P2Q2 | |
| PKKEEEQVPERGLVS | 471 | Q9P2D7 | |
| AVVLEIPVFEQKKPL | 256 | P0CF75 | |
| VPDEEQLFKKPRQVV | 231 | Q96DF8 | |
| RVIVEILKPEKPDLS | 4761 | Q4G0P3 | |
| KRIKVEKDLELPPAA | 686 | Q9C0K0 | |
| IVREKEPDLKLVQPI | 251 | Q9Y6J0 | |
| EPGIPKDEKLDAQVR | 96 | Q96HP0 | |
| ALVKLPDVLNRLKPD | 91 | Q9Y223 | |
| PAPRRLAENVKIKID | 921 | Q8TD57 | |
| KLRPDIGIKPTVIDV | 61 | Q99928 | |
| VIVEKAPKARVPDLD | 31 | Q9H0R8 | |
| KAVIPEAVVEVLDPK | 396 | O60678 | |
| LAELQLKEKAVPIPE | 761 | Q13698 | |
| ELRDNLPKEVRLSPK | 961 | Q5JV73 | |
| RVPKEVRVEPQKFAE | 376 | O15169 | |
| PSPVVIKKRIEGLIE | 736 | Q13618 | |
| QPRPLEESKVLVEKT | 2706 | Q8N3K9 | |
| LSDEEDQKPVRLPLK | 306 | Q96RY5 | |
| VAPEALQKKPEDTNR | 356 | Q13418 | |
| LIVEKAPKARVPDLD | 31 | Q9BY60 | |
| AKEEKISDIPIPERA | 26 | Q7Z388 | |
| ILDTDDLPKKRPAQI | 1111 | Q9Y2E4 | |
| LAPKDVKIRISAPQE | 321 | P61163 | |
| EVNLDEQDKITPKPR | 251 | Q5TB80 | |
| KELRQFVPGDEPREK | 221 | P09543 | |
| IEALPKVDLETVPKV | 366 | Q8IWC1 | |
| ELKKELPPREVSPLE | 1436 | Q6P0Q8 | |
| LPLARVKALVKADPD | 41 | Q9NR33 | |
| PEQTLLIKPEDIVLK | 661 | Q8N7U6 | |
| PVLNTAVKLIAPERK | 1691 | Q9H583 | |
| RVAVEAKNPADLPKL | 506 | P13639 | |
| DEDLKKRRVPQAKPV | 66 | Q8WUD4 | |
| VELLPKQLPDLRKEE | 2091 | Q9BYK8 | |
| VIKRPELLTEGVKEP | 636 | Q9UHL9 | |
| AIPKDKAILDIERPD | 46 | Q08495 | |
| KKRTEPPEQARLEFL | 251 | Q9P1V8 | |
| TEPKKLEENEVIPKR | 101 | P31431 | |
| KPVPQVDEAETRVVK | 191 | Q9NQZ2 | |
| VEEPEPKPDRLLVLK | 266 | O60779 | |
| PVERILEAELAVEPK | 231 | P19793 | |
| FESLLPDKVEKPRLQ | 126 | Q9BZW8 | |
| KLQFEPPLRKETEAR | 341 | Q9Y4K4 | |
| EATVPDLKRKPLDQI | 271 | Q6PHW0 | |
| IPEPKGKEIVSLLER | 171 | Q9ULK6 | |
| PEIQKVERFLKLSPQ | 226 | O14792 | |
| IEAKVEPALVVPINK | 326 | Q8IZC4 | |
| PLKFLDKARERPQVE | 91 | Q9NQ50 | |
| EVDIPAVKVKEEPRD | 211 | P05423 | |
| PEVPISEKAKDLILR | 346 | Q9Y2H1 | |
| EAKKGIELIPQVRIE | 906 | Q15147 | |
| LSELADPNPKVIKRI | 721 | A5PKW4 | |
| LPEIQKPERKIQFRE | 16 | Q9H9S3 | |
| ALIPREKKISILEEP | 126 | Q9NUQ6 | |
| IEALKQVADKLPRPN | 191 | Q8N103 | |
| KPPSDIQEIELRVKR | 6581 | Q8WXH0 | |
| RIKEIIEKLDQQIPP | 71 | Q6UWF7 | |
| NKPVLAKEDPIRAEE | 1021 | Q13393 | |
| RKFLKDQVLPPLRDV | 381 | Q9NVN3 | |
| VEPVDQLLRKVDPAK | 441 | O60861 | |
| PNPSLAQVKIEEAKR | 246 | Q96CS2 | |
| DVQKPRRSLEVIPEK | 1106 | Q9UPR0 | |
| NEILPPEKGREVAKE | 166 | Q9BYZ6 | |
| DKPIKLRPRSIEVEN | 221 | Q96B97 | |
| ILVESVKNPERKTVP | 831 | Q6IQ23 | |
| KLGILEKQPSPEEIR | 491 | Q9Y520 | |
| ADLPEGEKKPIDQRL | 116 | Q99460 | |
| IIDKPRIIEVAPQVA | 366 | P49903 | |
| VPVLKKRREVLPVDI | 446 | Q96EA4 | |
| RILVEVPTKIQKGPD | 141 | A0A087WV53 | |
| LEKPVEKVQRVEALP | 771 | Q9NWF9 | |
| KRPLQEDRLLPAEVK | 1356 | O95785 | |
| AALGPIRELKPEQVK | 556 | Q9UBP0 | |
| GPRRVKKDEDPVQIE | 156 | Q9NZP6 | |
| RVQDPLAELVKIEPK | 661 | Q8N5C6 | |
| KDPKPAIRFRLEQVV | 181 | Q5JPH6 | |
| QELEKLPLRENKRVP | 2031 | Q9H2D6 | |
| PSVVVPLEVIKENKR | 631 | Q8NFU7 | |
| LPSVEVDVQAPKAKL | 3601 | Q8IVF2 | |
| LEKFEIPVKIRLSPE | 671 | O95573 | |
| LVPDSRDPQKVKEFL | 121 | O95081 | |
| LSVRENPIIKNLKPE | 146 | Q9NWW5 | |
| AEPAEEAVIQKPRRK | 116 | Q96Q45 | |
| QKAEELVKDNELLPP | 61 | Q15025 | |
| IRKPDQVKLRLPISE | 256 | Q9P217 | |
| ALRPKPTLEKDLNVD | 211 | P0CG00 | |
| PQRLVDPKSKEEAII | 156 | Q9H2G4 | |
| VRLVPDLEKLEKVDQ | 1106 | Q13009 | |
| PLPDEKSRVAILKAN | 646 | P55072 | |
| VKLEPIVNLLPDKGR | 361 | Q96DM3 | |
| PPLVVAANIDEKTLK | 231 | Q9GZZ9 | |
| LPRAPEVQLKATKAE | 776 | Q9BXM0 | |
| FARTQEVKVDPDKPL | 56 | Q2M296 | |
| EVKVDPDKPLEGVRL | 61 | Q2M296 | |
| LELAVEVKQPEDRKP | 131 | P16471 | |
| KELPPELQIREKNER | 211 | Q8IWV7 | |
| VKPRVQETGEIKEPL | 1381 | Q709C8 | |
| AIEKQRLLEEKDPVP | 211 | Q13084 | |
| KNADLQVLKPEPELV | 231 | P01833 | |
| IKENEKPAVKAIEPA | 116 | Q6XYQ8 | |
| PKDPKLRELLDVGNI | 81 | Q9NQ66 | |
| DILKNLVEELPQPRK | 136 | Q9BYD1 | |
| ELQKLLERVPIPVKE | 1036 | O75643 | |
| LEIDEQRKTKPDPLI | 31 | Q8TCN5 | |
| PPSEVAEEKIQVKAL | 76 | P42681 | |
| PDLQVEVKPSIRARK | 616 | Q96KR1 | |
| NPPREGKKLLVLDVD | 131 | Q8WVY7 | |
| LDRKNQEAPISKDVP | 416 | Q5VWN6 | |
| PAPNEVLNDRKEDIK | 516 | Q9C0J8 | |
| IKPGDPRVLQKLDDD | 796 | Q9H9Y6 | |
| ELEKEPLRVIPLKEV | 226 | Q9HB21 | |
| EDKDKPDAKVRIIPL | 81 | Q9NVE5 | |
| PGKRKREDEAPILEQ | 1271 | Q14202 | |
| ILLQATKDPPEKLRV | 486 | Q12836 | |
| ILEDVVGVPEKKVLP | 466 | Q9ULW0 | |
| ENDIQKFPKLRVPIL | 51 | Q13094 | |
| PEEEEIPANRKIKFS | 446 | Q9ULJ8 | |
| PDTPEIRQVKKTQEA | 5036 | P20929 |